Randomized, double-blind, placebo-parallel controlled, multicenter, Phase III clinical trials of efficacy and safety of two low-concentration atropine sulfate eye drops (0.01%/0.02%) for delaying the progression of myopia in childre

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: 3dddb89c2951f6f2415ef18a74f3e312d3f7d79c
First added on: Apr 22, 2026